Volastra
Cindy O. is an accomplished professional in the pharmaceutical industry with extensive experience in clinical and business operations. Currently serving as Senior Director of Clinical & Business Operations at Volastra Therapeutics since May 2022, Cindy has previously held roles as Director at the same company, Associate Director at Zentalis Pharmaceuticals, and various positions including Associate Director and Sr Project Manager at Sumitomo Dainippon Pharma Oncology. Educational qualifications include a Master of Science in Biotechnology and a Bachelor of Science in Biology (Neurobiology) with Honors, both from Brown University, as well as an International Baccalaureate Diploma from the United World College of South East Asia.
This person is not in any teams
This person is not in any offices
Volastra
1 followers
Volastra Therapeutics, Inc., is developing novel therapies to treat and prevent the formation of metastatic disease. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and proliferation of metastases. Following initial evidence that a patient’s CIN status is prognostic for metastasis and that CIN alters metastasis and overall survival in mouse models, the company is discovering mechanisms and pathways by which CIN modulates metastatic disease to develop novel therapeutics.